Qiagen NV | QIA - Operating Expenses


Qiagen NV reported $393.64M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 952K 60K Jun/2026
argenx SE USD 1.24B 213M Sep/2026
Avita Medical AUD 28.56M 534K Jun/2026
Dianthus Therapeutics USD 62.24M 15.25M Jun/2026
Ionis Pharmaceuticals USD 373M 2.76M Sep/2026
IQVIA Holdings USD 3.82B 2.05B Sep/2026
Moderna USD 1.18B 223M Sep/2026
Organon & Co USD 1.19B 187M Sep/2026
Qiagen NV USD 393.64M 17.95M Jun/2026
Revvity USD 604.27M 719K Sep/2026
Tectonic Therapeutic USD 24.22M 3.08M Jun/2026
Viatris USD 3.49B 189.1M Sep/2026
Xeris Pharmaceuticals USD 86.93M 11.72M Jun/2026